Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

By R. Müller, M. Radtke, S. Wissing. Advanced Drug Delivery Reviews, 2002

2,006 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/a096ab6d012c9447ca028647e3715141dad05999

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Microneedles: A New Frontier in Nanomedicine Delivery (2016, unknown): “Conversely, NLC are formed by a solid lipidic matrix comprising a mixture of liquid and solid lipids encapsulating a liquid lipidic nanocompartment (43).”
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. (2015, methodology): “These are including solid solution model, core-shell model (drugenriched Shell) and core-shell model (drug-enriched core) which is shown in Figure 2.(25,31,32)”
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, unknown): “NLCs were developed in 1999/2000 by Muller et al. (2002) to improve the burst release problem observed with SLNs. NLCs are lipid nanoparticles composed of a solid lipid matrix incorporated with liquid lipid or oil (Fig.”
Nanostructured lipid carriers: Promising drug delivery systems for future clinics. (2016, background): “Actually, topical application, either for therapeutic or cosmetic purposes is a research area in which NLCs have been used since the 1990’s with promising results.(36) The literature is rich on publications on the ability of lipid-based particles and vesicular colloidal carriers to penetrate the SC ”
Silver nanoparticles: behaviour and effects in the aquatic environment. (2011, background): “, 2007; Dong and Feng, 2007; Salata, 2004), cosmetics (Lens, 2009; Müller et al., 2002), renewable energies (Pavasupree et al.”
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery (2011, background): “In contrary, several disadvantages are also associated with SLNs (45, 46 ), such as: (a) SLN dispersions contain high amount of water, (b) drug-loading capacity of SLNs are limited due to crystalline structure of solid lipid, (c) expulsion of encapsulated drug may take place during storage due to fo”
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. (2004, unknown): “As a result of film formation after topical application occlusive properties were also reported ( Müller et al., 2002; Wissing and Müller, 2001, 2002a ; Wissing et al., 2001).”